消化道出血行内镜治疗后发生早期再出血的危险因素分析

目的分析影响消化道出血行内镜治疗后发生早期再出血的危险因素。方法选取2016年1月-2018年12月在该院接受内镜治疗的消化道出血患者167例,按内镜治疗后是否发生早期再出血分为再出血组(n=33)及对照组(n=134),查阅病历资料统计相关影响因素,多因素Logtisic回归分析影响消化道出血行内镜治疗后发生早期再出血的危险因素。结果Glasgow-Blatchford危险评分(GBS)、Rockall危险评分(RS)、急性上消化道出血AMIS65评分、入院时血红蛋白值及血小板指数是消化道出血行内镜治疗后发生早期再出血的独立影响因素(P<0.05)。结论消化道出血行内镜治疗的患者,应重视术前GBS、RS、AMIS65评分、入院时血红蛋白和血小板指数水平,严密监测,积极预防早期再出血。

Risk factors of occurrence of early rebleeding after endoscopic therapy of gastrointestinal bleeding*

Objective To analyze the risk factors of occurrence of early rebleeding after endoscopic therapy of gastrointestinal bleeding.Methods 167 patients with gastrointestinal bleeding who underwent endoscopic therapy from January 2016 to December 2018 were divided into rebleeding group(n=33)and control group(n=134)according to the presence or absence of early rebleeding after endoscopic therapy,and the medical records were reviewed to count related influencing factors,and multivariate Logistic regression analysis was used to analyze the risk factors of occurrence of early rebleeding after endoscopic therapy of gastrointestinal bleeding.Results Glasgow-Blatchford risk score(GBS),Rockall risk score(RS),acute upper gastrointestinal bleeding AMIS65 score,and hemoglobin value and platelet index at admission were independent influencing factors for occurrence of early rebleeding after endoscopic therapy of gastrointestinal bleeding(P<0.05).Conclusion For patients underwent endoscopic therapy of gastrointestinal bleeding or patients with supra-thresholds of preoperative GBS,RS and AMIS65 scores and levels of hemoglobin and platelet index at admission,it is necessary to closely monitor and actively prevent early rebleeding.